Related Experiment Video

Updated: Aug 17, 2026

A Murine Closed-chest Model of Myocardial Ischemia and Reperfusion
13:42

A Murine Closed-chest Model of Myocardial Ischemia and Reperfusion

Published on: July 17, 2012

HO-1 induction by HIF-1: a new mechanism for delayed cardioprotection?

Buddhadeb Dawn, Roberto Bolli

    American Journal of Physiology. Heart and Circulatory Physiology
    |July 15, 2005
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model
    08:22

    In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model

    Published on: October 27, 2020

    Related Experiment Videos

    Last Updated: Aug 17, 2026

    A Murine Closed-chest Model of Myocardial Ischemia and Reperfusion
    13:42

    A Murine Closed-chest Model of Myocardial Ischemia and Reperfusion

    Published on: July 17, 2012

    In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model
    08:22

    In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model

    Published on: October 27, 2020

    Related Concept Videos

    Regulation of Angiogenesis and Blood Supply01:24

    Regulation of Angiogenesis and Blood Supply

    Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...

    Articles linked to this work by shared authors, journal, and citation graph.

    Changes in Circulating Biomarkers in Patients With Ischemic Heart Failure After Treatment With Autologous Mesenchymal Stromal Cells and c-Kit-Positive Cardiac Cells, Alone or in Combination: Results From the Cardiovascular Cell Therapy Research Network CONCERT-HF Clinical Trial.

    Journal of the American Heart Association·2026

    Machine Learning Identifies Distinct Treg-Mediated Remodeling in HFpEF Hearts Treated with Neonatal Mesenchymal Stem Cells and Their Secretome.

    bioRxiv : the preprint server for biology·2026

    Design and rationale of CATO, a Phase IIA, randomized, double-blind, placebo-controlled study of single or repeated intravenous administration of umbilical cord-derived mesenchymal stromal cells in ischemic cardiomyopathy.

    American heart journal·2025

    Comparative Effects of Repeated Intravenous Infusions of Progenitor Cells in a Rat Model of Chronic Ischemic Cardiomyopathy.

    Stem cell reviews and reports·2025

    Cell therapy for heart failure -recent progress and future directions.

    Progress in cardiovascular diseases·2025

    A new model of heart failure with preserved ejection fraction induced by metabolic syndrome in Ossabaw miniature swine.

    Basic research in cardiology·2025

    Formate reduces cardiac ischemia-reperfusion injury in murine ex vivo and in vitro models.

    American journal of physiology. Heart and circulatory physiology·2026

    Role of epigenetic factors during blockade of the Renin-Angiotensin system across aging.

    American journal of physiology. Heart and circulatory physiology·2026

    Impaired CD4+ T cell response to apolipoprotein B-100 peptide P210 in atherosclerotic cardiovascular disease is reversed by P210-conjugated nanoparticles.

    American journal of physiology. Heart and circulatory physiology·2026

    Preserved diastolic carotid blood flow is associated with higher diastolic aortic pressure in lifelong female pearl divers.

    American journal of physiology. Heart and circulatory physiology·2026

    Selective Pharmacological Blockade of GPR39 Reduces No Reflow and Infarct Volumes in a Rat Acute Myocardial Infarction When Administered Prior to Reperfusion.

    American journal of physiology. Heart and circulatory physiology·2026

    Validation of the Detection of The Salt Sensitivity of Blood Pressure from 24-hour Ambulatory Blood Pressure Monitoring Data.

    American journal of physiology. Heart and circulatory physiology·2026

    Long-term outcome of pediatric anti-complement factor H antibody-associated atypical hemolytic uremic syndrome receiving abbreviated plasma exchange: a retrospective study from a single center.

    Journal of nephrology·2026

    [Therapeutic apheresis in first-line treatment of hematological disorders - an evidence-based review].

    Therapeutische Umschau. Revue therapeutique·2026

    Same-day rescue plerixafor during leukapheresis is safe and effective in allogeneic donors suboptimally responding to granulocyte colony-stimulating factor mobilization.

    Transfusion·2026

    Platelet-erythrocyte complex production is exacerbated by histones and protected by small polyanion histone neutralizing compounds.

    Platelets·2026

    Changing the treatment paradigm in beta thalassemia.

    Folia medica·2026

    Noninvasive Thrombus Imaging in Patients With Ischemic Stroke.

    Circulation·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us